nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-F6F40C5C·Framework v5.9·Pipeline v0.4·Evaluated 08 Oct 2026·OECD: 3.2 Clinical medicine·Subfield: General Health Professions·Basis: Full text·Type: Mixed-methods study

Factors influencing implementation of an Alzheimer's disease blood test among UK old age psychiatrists: mixed-methods study using the theoretical domains framework.

Jemma et al.Jemma, Mealing, Lorencatto et al.·2026·Age and ageing·10.1093/ageing/afag117 ↗

Primary claim

This study identified barriers and enablers to AD BBM implementation across TDF domains, highlighting diagnostic benefits and resource challenges.

Supported · mixed-method evidence identifies respondent perceptions, but the selected sample limits population-level inference
In brief

A useful framework-based map of psychiatrist-reported implementation barriers whose workforce relevance is constrained by a 3.3% response rate.

ReliabilityCaveats4 of 4 checks completeRead the entry ↓
Fragile — the claim's weakest requirement is that it holds beyond the sample studied. Based on how the study was designed and conducted, not on statistics extracted from the paper. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract

INTRODUCTION: Only 6% of UK memory services meet Alzheimer's disease (AD) biomarker access guidelines, limiting psychiatrists' experience. Emerging AD blood biomarker (BBM) tests will potentially expand access. Exploring implementation barriers and enablers a priori can inform rollout strategies. This study examined current clinical practises, barriers and enablers to implementation and potential interventions to support implementation.

METHODS: In November 2024, Royal College of Psychiatrists Old Age Psychiatry Faculty members (n = 172) participated in an online survey and four focus groups (n = 16 participants), informed by the Theoretical Domains Framework (TDF) and Behaviour Change Wheel. Demographic data were summarised descriptively. Mean (SD) belief statement scores for TDF domains and percentage agreement were calculated. Multiple linear regression examined associations between TDF domains and intention to use BBMs.

RESULTS: Respondents were mainly consultants in England; <33% had used biomarkers. Key barriers to use were: 'Knowledge,' 'Environmental Context and Resources' and 'Goals.' Enablers included: 'Behavioural Regulation,' 'Social Influences' and 'Intention.' Mixed enablers/barriers included: 'Beliefs about Consequences', 'Optimism' and 'Social/Professional Role & Identity'. In regression analyses, 'Memory, Attention and Decision Processes' (B = 0.44, 95%CI 0.20-0.68), 'Beliefs about Consequences'(B = 0.45, 95%CI 0.11-0.78), and 'Social Influences' (B = 0.24, 95%CI 0.04-0.44) were positively associated with intention, while 'Optimism' (B = -0.31,95% CI-0.58 to-0.04) and 'Emotion' (B = -0.33, 95%CI -0.60 to-0.06) were negatively associated. Key interventions were 'Guidelines' (e.g. appropriate use criteria) and 'Environmental Restructuring' to expand resources and re-organise pathways.

DISCUSSION: A complex interplay of barriers and enablers influences AD BBM implementation. Interventions targeting clinician, service and policy levels are required to support their introduction.

Key Claims

Primary finding · Supported

This study identified barriers and enablers to AD BBM implementation across TDF domains, highlighting diagnostic benefits and resource challenges.

Fragile — the claim's weakest requirement is that it holds beyond the sample studied. Based on how the study was designed and conducted, not on statistics extracted from the paper. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

mixed-method evidence identifies respondent perceptions, but the selected sample limits population-level inference

Conclusions
Quote verified
Secondary · Supported

Key barriers to use were: ‘Knowledge,’ ‘Environmental Context and Resources’ and ‘Goals.’

survey percentages and qualitative findings converge, though classification rules and representativeness remain uncertain

Abstract; Results, Barriers and Enablers to AD BBM Use
Quote verified
Secondary · Supported

‘Memory, attention and decision processes’ (B = 0.44, 95% CI 0.20 to 0.68), ‘Beliefs about Consequences’ (B = 0.45, 95% CI 0.11 to 0.78) and ‘Social Influences’ (B = 0.24, 95% CI 0.04 to 0.44) were positively associated with ‘Intentions.’

reported regression estimates support association, while the cross-sectional, ceiling-affected intention outcome limits interpretation

Results, Linear Regression Analyses
Quote verified
Secondary · Tentative

Key interventions were ‘Guidelines’ (e.g. appropriate use criteria) and ‘Environmental Restructuring’ to expand resources and re-organise pathways.

near-universal endorsement across several strategies prevents strong prioritisation of these two options

Abstract; Results, Interventions
Quote verified
Secondary · Tentative

UK Survey respondents from the Royal College of Psychiatrists Old Age Faculty have very limited experience of Alzheimer’s disease biomarker investigations. This may more broadly reflect the experience of UK memory service psychiatrists.

within-sample experience is documented, but the 3.3% response rate cannot establish broader workforce prevalence

Key Points, bullet 1
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#methodological rigour

Theory-linked mixed-methods implementation design

The survey and focus groups use the TDF as a common framework, with BCW mapping used to connect identified determinants to candidate intervention functions. Quantitative and qualitative findings are integrated through narrative triangulation.

↳ Methods, Analyses and Focus Groups, Data Analysis

#methodological rigour

Transparent analysis and diagnostic reporting

The paper reports regression assumption checks, confidence intervals and sensitivity analyses adjusting for consultant role and region. Independent coding and illustrative quotations provide an interpretable qualitative audit trail.

↳ Methods, Analyses; Results, Linear Regression Analyses

#application pathway

Visible pathway to policy use

The implications identify appropriate-use criteria, pathway redesign and NHS England system-readiness work as concrete routes through which the findings could inform planning.

↳ Implications for Clinical Practise and Policy

Limitations

#methodological rigour

Very low and selective participation

Only 172 complete responses were obtained from 5,269 invitees, with 28.9% dropout among those starting the survey. The English, consultant and academic-centre concentration limits workforce-level interpretation.

↳ Results, Demographic Characteristics; Discussion, Strengths and Limitations

#reporting

Inconsistent barrier and enabler reporting

The Abstract treats Optimism as mixed and Intention as an enabler, while Results describe Optimism as an overall enabler and Methods reserve Intention as the regression outcome. No explicit classification threshold is reported.

↳ Abstract; Methods, Analyses; Results, Optimism and Linear Regression Analyses

#contribution

Interventions remain untested and weakly prioritised

Most proposed intervention functions received 94–98% agreement, limiting discrimination among strategies. The paper therefore supplies inputs for co-design rather than evidence that guidelines, training or restructuring will improve adoption.

↳ Results, Interventions; Implications for Clinical Practise and Policy

Does this match your read? Add your assessment ↓

Nabu Commentary

The TDF/BCW structure, mixed-methods design, independent coding and regression diagnostics support a useful pre-implementation account of clinician perceptions. The score is moderated by the 3.3% response rate, 28.9% dropout and complete-case analysis, which make prevalence estimates and workforce generalisation uncertain. Abstract–Results differences in domain classification and focus-group timing reduce reporting precision, while no explicit barrier/enabler decision rule is given. The proposed intervention functions are relevant to NHS planning but remain untested and were endorsed too uniformly to establish clear priorities.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.5±0.2

Contribution
3.5

The study adds UK old-age-psychiatrist evidence using the TDF and BCW, extending prior biomarker surveys and the authors’ qualitative synthesis. The advance remains an early implementation-readiness map rather than evidence that a proposed intervention works.

Introduction, final paragraph; Discussion, Strengths and Limitations

research specifically focused on UK psychiatrists’ perspectives remains limited

Methodological Rigour
3.4

The design combines a theory-based survey, regression, independent qualitative coding and narrative triangulation, with assumption checks and sensitivity analyses. Confidence is reduced by unassessed self-report measurement error, absent researcher positionality and a highly selected complete-case sample.

Methods, Analyses and Focus Groups, Data Analysis; Results, Demographic Characteristics

Analyses were performed using R version 4.1.2 using complete responses.

Reporting
3.6

The main sequence from implementation question through TDF findings and BCW implications is followable. Precision is reduced by inconsistent domain classifications and focus-group dates across the Abstract, Methods and Results.

Abstract; Methods, Cross-Sectional Survey; Results, Demographic Characteristics and Optimism

‘Optimism’ was overall an enabler to AD BBM implementation

Positioning
3.7

The discussion connects findings to prior biomarker surveys, implementation literature and NHS readiness planning, and traces major design limitations to interpretation. Engagement is more extensive with implementation-supportive literature than with countervailing clinical or operational evidence.

Discussion; Strengths and Limitations; Implications for Clinical Practise and Policy

Generalisability of study findings must be interpreted cautiously in light of the low response rate.

Reliability

Caveats4 of 4 checks


Results checkClean

The reported numbers and statistics are consistent with the stated results.

Reporting and transparencyNoted

The Abstract and Results use different labels for Optimism and give different focus-group dates, and the domain-classification decision rule is not explicitly reported; none establishes that a key result is incorrect.

Conflict of interest: not stated · Ethics approval: declared · Preregistration: not stated · Data availability: declared · Code availability: not stated

Reference IntegrityClean

47 references in manuscript 37 of 37 checkable references found in an index 10 have no canonical index record — counted, but not index-checkable 1 reference confirmed by manual review

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Neurological · Alzheimer's disease and other dementias
Type of advanceEmpirical
Route to useNamed
AdvanceExtends
BeneficiariesLarge
CitationsToo early
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessFoundational
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The claim rests on a descriptive cross-sectional survey and focus groups capturing self-reported perceptions and intention, with no intervention designed, piloted or implemented and no actual test use observed.

From the paper
“Clinical pathways for AD BBM use should build on global recommendations [46], supported by national policy and NHS England guidance.”

The paper names specific actors (NHS England, national policy bodies, UK health and dementia organisations, memory services) and their purposes (appropriate-use guidelines, clinical pathways, service resourcing and training), though without detailing the concrete decision points.

Pathway

Findings could inform NHS England, royal colleges and dementia organisations developing appropriate-use guidelines, training and restructured memory-service pathways for AD blood test rollout.

Barrier

Findings rest on a small self-selected sample measuring intention, and a tested intervention plus approved, resourced blood tests are still needed.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Implementation and development of an embedded researcher program driven by rural health services: a qualitative exploratory case study

    King, Beks, Beauchamp, et al. · 2025 · Health sciences

    Primary claim

    The rural embedded researcher program represents an evolving, yet ostensibly successful initiative implemented across a large rural and regional area.

    Tentative
    Evidence Score
    3.3±0.2
    Reliability
    No concerns
  2. Bridging Research, Policy, and Practice: Advancing Evidence-Informed Approaches for Dementia Care and Prevention: an expert review by the Health Policy Professional Interest Area from ISTAART

    Souza-Talarico, Pinzon, Viswanathan, et al. · 2026 · Public health and health services

    Primary claim

    Gaps in dementia policy arise less from absent evidence than from limitations in mobilizing and applying existing knowledge.

    Tentative
    Evidence Score
    3.1±0.2
    Reliability
    Caveats
  3. What are the lived career experiences of senior operating department practitioners? An interpretative phenomenological analysis

    Lee Rollason · 2025 · Health sciences

    Primary claim

    ODPs value high-quality care but they are also methodical, scientific practitioners.

    Supported
    Evidence Score
    2.8±0.2
    Reliability
    Caveats

How the rubric works →